Stay updated with breaking news from Transplant Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of rejection, both of which may carry complications. Now, a simple, urine-based assay that detects the CXCL10 chemokine may make care more convenient and less ...
According to Market.us, the Transplant Diagnostics Market is projected to reach approximately USD 8.3 Billion by 2032, up from USD 4.5 Billion recorded in 2023. This growth is anticipated to occur at a compound annual growth rate (CAGR) of 7.2% between the forecast period spanning from 2023 to 2032.The Transplant Di...
Agreement grants rights to further develop an assay for pre-transplant prognostic testing. CARDIFF, U.K. , November 15, 2023 / B3C newswire / -- Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced that it has signed an exclusive global licensing agreement wit...
Verici DX Plc Reaches a Global Licensing and Commercialisation Agreement with Thermo Fisher Scientific Agreement grants rights to further develop an assay for pre-transplant prognostic testing. CARDIFF, U.K. , November 15, 2023 / B3C newswire / -- Verici Dx plc (AIM: VRCI), a developer o...
The global transplant diagnostic market is set to record a healthy CAGR of 5.73% during the forecast period. Pivotal factors contributing to market growth...